<< Exhibitor
<< Press release
The 12th China IVD Industry Development Conference is set to take place on 22-23 March 2025, at the Hangzhou Grand Convention and Exhibition Center.
The 22nd China International In Vitro Diagnostic Expo by CACLP will take place from 22-24 March 2025 at the Hangzhou Grand Convention & Exhibition Center in Hangzhou, China, alongside a range of concurrent activities starting from 21 March to enhance the overall event experience.
In collaboration with the International Trade Administration and U.S. Commercial Service, China Association of In Vitro Diagnostics (CAIVD) and CACLP are excited to announce a global webinar focused on China’s IVD market.
Taking place 22-24 March at the Hangzhou Grand Convention & Exhibition Center, CACLP 2025—the 22nd China International In Vitro Diagnostic Expo—will make a significant impact, bringing a sharp focus to global innovation and industry collaboration. With the theme "Innovation for a Better Future", the event is set to bring together industry leaders and emerging players. The preliminary exhibitor list features an impressive range of global participants, ready to showcase cutting-edge advancements and connect with local resources in China’s fast growing in vitro diagnostics (IVD) market.
At the 7th China International Import Expo (CIIE), themed "New Era, Shared Future", representatives from 152 countries, regions, and organizations gathered for national and corporate exhibitions. On 8 November, Switzerland Global Enterprise (S-GE) visited the China Association of In Vitro Diagnostics (CAIVD) to explore future collaboration and growth opportunities in the field of in vitro diagnostics (IVD).
On 26 October 2024, China Association of In-Vitro Diagnostics (CAIVD) hosted the IVD Youth Entrepreneur' Working Conference in Hangzhou. Representatives from over 20 IVD companies were invited to participate in this gathering.
On 26 October 2024, China Association of In-Vitro Diagnostics (CAIVD) hosted the Distribution Enterprises Work Conference in Hangzhou, bringing together representatives from over 50 in vitro diagnostics (IVD) distribution enterprises.
On 26 October 2024, the Working Conference of the In Vitro Diagnostics Industrial Development Institute (IIDI), part of the Shanghai Academy of Experimental Medicine (SAEM), took place in Hangzhou.
On 26 October 2024, China Association of In-Vitro Diagnostics (CAIVD) held its Raw Materials & Parts Working Conference in Hangzhou, attracting close to 20 distinguished representatives from industry, academia, and research.
On 25-26 October, 2024, China Association of In-Vitro Diagnostics, National Association Health Industry Enterprise Management, held its expanded working meeting in Hangzhou, China, focusing on strategic developments in the in-vitro diagnostics (IVD) sector.
<< Industry news
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the initial phase of a program to improve provider access to GRAIL’s Galleri® multi-cancer early detection (MCED) test. Providers can now order the Galleri test directly from GRAIL through the Quest Diagnostics connectivity system. The Quest Diagnostics connectivity system enables providers in the United States to order and receive reports of laboratory tests electronically through Quest’s Quanum laboratory portal and more than 900 electronic health record (EHR) systems. More than 500,000 providers used the Quest connectivity system last year.
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced financial results for the fourth quarter and full-year ended December 29, 2024.
The Nasdaq Hearings Panel has decided to delist T2 Biosystems common stock after the firm failed to meet the stock exchange's requirements for the minimum bid price and market value of listed securities, T2 Biosystems said in a form filed Tuesday with the US Securities and Exchange Commission.
bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid has obtained clearance from the U.S. Food and Drug Administration (FDA). This midplex molecular panel tests for 11 of the most common bacteria, viruses, and parasites associated with gastroenteritis — all from one sample, with results available in approximately one hour.
Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.
In vitro fertilization embryos are prone to chromosomal aneuploidy abnormalities. Chromosome aneuploidy refers to the increase or decrease in the number of a single chromosome or multiple chromosomes.
Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Ibex Prostate Detect, an in vitro diagnostic medical device that harnesses AI to generate heatmaps identifying small and rare missed prostatic cancers, acting as a safety net that assists pathologists in ensuring patients receive an accurate diagnosis.
MRC Holland said Thursday that its blood-based assay for Temple, Kagami-Ogata, and Russell-Silver syndromes has received certification under Europe's In Vitro Diagnostic Regulation (IVDR).
Imagene, a leader in AI-powered Oncology Intelligence, today announced a collaboration with Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care. The collaboration aims to advance cancer diagnostics by accelerating biomarker prediction, integrating AI-powered tools into clinical workflows, and enabling the commercialization of accessible diagnostic solutions.
Illumina, Inc. (Nasdaq: ILMN) (“Illumina” or the “company”) today announced its financial results for the fourth quarter and fiscal year 2024. The financial results for fiscal year 2024 and Q4 2023 and fiscal year 2023 include the financial results for GRAIL which was spun off on June 24, 2024.
<< Video showcase
International Laboratory Medicine and In Vitro Diagnostic Forum
The 11th China IVD Industry Development Conference (CIIDC)
The 9th China Experimental Medicine Conference (CEMC)
CACLP 2024 onsite - The Convergence of Laboratory Medicine and In Vitro Diagnostics
CACLP APP is available for download now!
Gentian at CACLP 2023 Onsite
in.vent Diagnostics at CACLP 2023 Onsite
Charming Group at CACLP 2023 Onsite
Dialab at CACLP 2023 Onsite
JTC at CACLP 2023 Onsite
Certest at CACLP 2023 Onsite
Yashraj Biotechnology at CACLP 2023 Onsite
Magtivio at CACLP 2023 Onsite
The 8th China Experimental Medicine Conference (CEMC)
The 10th China IVD Industry Development Conference (CIIDC)
CACLP 2023 onsite - The Convergence of Laboratory Medicine and In Vitro Diagnostics
CACLP's new website is launching!
Autobio on Medlab Middle East 2023
EasyDiagnosis on Medlab Middle East 2023
BioPerfectus on Medlab Middle East 2023
<< Download centre
CACLP & CISCE 2024 Draw Global Attention to Innovations and Collaborations in IVD Industry
CACLP & CISCE to present the latest in IVD with 1300+ Exhibitors and 100+ Concurrent Activities this March in Chongqing.pdf
CACLP & CISCE 2024 - Floor Plan
CACLP & CISCE 2024 - Exhibitor Manual
1200+ Global Exhibitors Confirmed Their Participation on the 21st CACLP and 4th CISCE in Chongqing, March 2024
CACLP & CISCE 2023 Post-show Report
Over 1,100 Exhibitors Commit to Attend the 2024 China Association of Clinical Laboratory Practice Expo (CACLP) and China IVD Supply Chain Expo (CISCE)
CACLP & CISCE 2024 Flyer
Chongqing – The Next Station for China Association of Clinical Laboratory Practice Expo & China IVD Supply Chain Expo in 2024
The 20th CACLP & 3rd CISCE Closed with Record-breaking Numbers in Nanchang Last Week
Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.